The Discounted Cash Flow (DCF) valuation of Indofarma Tbk PT (INAF.JK) is (1,208.37) IDR. With the latest stock price at 126.00 IDR, the upside of Indofarma Tbk PT based on DCF is -1059.0%.
Based on the latest price of 126.00 IDR and our DCF valuation, Indofarma Tbk PT (INAF.JK) is a sell. selling INAF.JK stocks now will result in a potential gain of 1059.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.4% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (2,164.72) - (909.47) | (1,208.37) |
| Upside | -1818.0% - -821.8% | -1059.0% |